1
EPISODE · Apr 24, 2026 · 16 MIN
FDA Approves Psychedelic Drug Trials, Signaling Shift in Mental Health Treatment
from 1nessAgency Insights
The FDA's decision in early 2026 to back three psychedelic drug studies for mental illness treatment marks the clearest regulatory signal yet that psychedelic-assisted therapy is on a trajectory toward mainstream clinical use , and healthcare systems that wait for full approval before building their
Embed this episode
NOW PLAYING
FDA Approves Psychedelic Drug Trials, Signaling Shift in Mental Health Treatment
0:00
16:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 1nessAgency Insights?
This episode is 16 minutes long.
When was this 1nessAgency Insights episode published?
This episode was published on April 24, 2026.
Can I download this 1nessAgency Insights episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!